The Role of the Met66 Brain-Derived Neurotrophic Factor Allele in the Recovery of Executive Functioning after Combat-Related Traumatic Brain Injury

• DOI: 10.1523/jneurosci.1399-10.2011
• Publication Date: 2011-01-12T17:23:23Z
• Authors: Frank Krueger; Matteo Pardini; Edward D. Huey; Vanessa Raymont; Jeffrey Solomon; Robert H. Lipsky; Colin A. Hodgkinson; David Goldman; Jordan Grafman
• Keywords: Male; Warfare; Polymorphism, Genetic; Brain-Derived Neurotrophic Factor; Valine; Wounds, Penetrating; Recovery of Function; Middle Aged; Frontal Lobe; 3. Good health; 03 medical and health sciences; Methionine; 0302 clinical medicine; Brain Injuries; Linear Models; Humans; Veterans

Brain-derived neurotrophic factor (BDNF), a member of the neurotrophin family, promotes survival and synaptic plasticity in the human brain. The Val66Met polymorphism of the BDNF gene interferes with intracellular trafficking, packaging, and regulated secretion of this neurotrophin. The human prefrontal cortex (PFC) shows lifelong neuroplastic adaption implicating the Val66Met BDNF polymorphism in the recovery of higher-order executive functions after traumatic brain injury (TBI). In this study, we examined the effect of this BDNF polymorphism on the recovery of executive functioning after TBI. We genotyped a sample of male Vietnam combat veterans consisting of a frontal lobe lesion group with focal penetrating head injuries and a non-head-injured control group for the Val66Met BDNF polymorphism. The Delis–Kaplan Executive Function System as a standardized psychometric battery was administrated to examine key domains of executive functions. The results revealed that the Met allele but not the hypothesized Val allele promotes recovery of executive functioning. Overall, the Met66 carriers in the lesion group performed as well as the Met66 carriers in the control group. The Met66 allele accounted for 6.2% of variance for executive functioning independently of other significant predictors including preinjury intelligence, left hemisphere volume loss, and dorsolateral PFC volume loss. The findings point to different mechanisms of the Val66Met BDNF gene in complex phenotypes under normal and pathological conditions. A better understanding of these mechanisms could be instrumental in the development and application of effective therapeutic strategies to facilitate recovery from TBI.